CYNTHIA BANWELL: Open Payments
NPI 1124704911 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,358 in 71 payments from 14 companies in 2025. Trend: 2023 $220 · 2024 $1,131 · 2025 $1,358
Food & beverage: $1,358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $311 |
| Otsuka America Pharmaceutical, Inc. | 12 | $234 |
| Axsome Therapeutics, Inc. | 4 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $142 |
| Lundbeck LLC | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 5 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, FANAPT, COBENFY, Qelbree, Jornay PM.
Industry payments across TX — which companies pay providers there.
